Amplify Treatments, Testing And Advancements ETF LH Holdings History
Number of Shares
2,958.00
Current Holdings Value*
$601,980.00
% of Portfolio
6.59%
Total Estimate Gain
$92,635.44
% of Total Estimate Gain
13.83%
Amplify Treatments, Testing and Advancements ETF's Labcorp Holdings Inc Holding Summary
As of 2024-06-30, Amplify Treatments, Testing and Advancements ETF held 2,958.00 shares of Labcorp Holdings Inc(LH), totaling $601,980.00. This investment constitutes 6.59% of their stock portfolio, and Amplify Treatments, Testing and Advancements ETF now holds 0% of the outstanding Labcorp Holdings Inc(LH) stock.
The initial trade took place in 2024Q1. In addition, there have been 1 sales at an average price of $203.42 for 83.00 shares. Based on historical transaction data and LH's current price of $252.07, Amplify Treatments, Testing and Advancements ETF's estimated gain on his LH holdings is $92,635.44, reflecting a 13.83% gain to date.
Amplify Treatments, Testing and Advancements ETF LH ($252.07) Holding Chart
Amplify Treatments, Testing and Advancements ETF LH ($252.07) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1